• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺毛细血管后肺动脉高压对间质性肺疾病死亡率的影响。

Impact of post-capillary pulmonary hypertension on mortality in interstitial lung disease.

机构信息

Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.

Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi, Japan.

出版信息

Respir Investig. 2021 May;59(3):342-349. doi: 10.1016/j.resinv.2020.12.010. Epub 2021 Feb 10.

DOI:10.1016/j.resinv.2020.12.010
PMID:33579646
Abstract

BACKGROUND

Pulmonary hypertension (PH) influences mortality in patients with interstitial lung disease (ILD). Almost all studies on patients with ILD, have focused on the clinical impact of pre-capillary PH on survival. Therefore, little is known about the influence of post-capillary PH. We aimed to assess the prevalence of post-capillary PH and its clinical impact on survival in patients with ILD, followed by comparison with pre-capillary PH.

METHODS

This retrospective study enrolled 1152 patients with ILD who were diagnosed with PH using right heart catheterization between May 2007 and December 2015. We analyzed the demographics and composite outcomes (defined as death from any cause or lung transplantation) of patients with post-capillary PH and compared them with patients with pre-capillary PH.

RESULTS

Thirty-two (20%) of the 157 patients with ILD-PH were diagnosed with post-capillary PH. Patients with post-capillary PH had significantly lower modified Medical Research Council scores, higher diffusion capacity for carbon monoxide, higher resting PaO, lower pulmonary vascular resistance (PVR), and higher lowest oxygen saturation during the 6-min walk test compared to those with pre-capillary PH. Cardiovascular diseases were associated with a higher risk of mortality in patients with post-capillary PH. Multivariate Cox proportional hazards analysis demonstrated no significant difference between the composite outcomes in pre-capillary and post-capillary PH, while PVR and the ILD Gender-Age-Physiology Index were significantly associated with the composite outcome.

CONCLUSIONS

We found that approximately one-fifth of patients with ILD-PH were diagnosed with post-capillary PH, and that PVR and not post-capillary PH was associated with mortality.

摘要

背景

肺动脉高压(PH)影响间质性肺疾病(ILD)患者的死亡率。几乎所有关于ILD 患者的研究都集中在毛细血管前 PH 对生存的临床影响上。因此,关于毛细血管后 PH 的影响知之甚少。我们旨在评估 ILD 患者中毛细血管后 PH 的患病率及其对生存的临床影响,并与毛细血管前 PH 进行比较。

方法

这项回顾性研究纳入了 2007 年 5 月至 2015 年 12 月期间通过右心导管检查诊断为 PH 的 1152 例 ILD 患者。我们分析了毛细血管后 PH 患者的人口统计学特征和复合结局(定义为任何原因导致的死亡或肺移植),并将其与毛细血管前 PH 患者进行了比较。

结果

在 157 例 ILD-PH 患者中,有 32 例(20%)被诊断为毛细血管后 PH。与毛细血管前 PH 患者相比,毛细血管后 PH 患者的改良医学研究理事会评分明显较低,一氧化碳弥散量较高,静息 PaO 较高,肺血管阻力(PVR)较低,6 分钟步行试验中最低血氧饱和度较高。心血管疾病与毛细血管后 PH 患者的死亡风险增加相关。多变量 Cox 比例风险分析表明,毛细血管前和毛细血管后 PH 的复合结局之间无显著差异,而 PVR 和 ILD 性别-年龄-生理指数与复合结局显著相关。

结论

我们发现,大约五分之一的 ILD-PH 患者被诊断为毛细血管后 PH,并且与死亡率相关的是 PVR,而不是毛细血管后 PH。

相似文献

1
Impact of post-capillary pulmonary hypertension on mortality in interstitial lung disease.肺毛细血管后肺动脉高压对间质性肺疾病死亡率的影响。
Respir Investig. 2021 May;59(3):342-349. doi: 10.1016/j.resinv.2020.12.010. Epub 2021 Feb 10.
2
Clinical and hemodynamic characteristics of pulmonary hypertension associated with interstitial lung disease in China.中国间质性肺疾病相关肺动脉高压的临床和血流动力学特征
Clin Respir J. 2018 Mar;12(3):915-921. doi: 10.1111/crj.12604. Epub 2017 Jan 6.
3
Borderline pulmonary hypertension is associated with exercise intolerance and increased risk for acute exacerbation in patients with interstitial lung disease.特发性肺动脉高压与运动不耐受和间质性肺疾病患者急性加重的风险增加有关。
BMC Pulm Med. 2019 Sep 2;19(1):167. doi: 10.1186/s12890-019-0932-5.
4
Pulmonary Vascular and Right Ventricular Burden During Exercise in Interstitial Lung Disease.特发性肺纤维化患者运动时的肺血管和右心室负荷。
Chest. 2020 Jul;158(1):350-358. doi: 10.1016/j.chest.2020.02.043. Epub 2020 Mar 12.
5
Hemodynamic Response to Treatment and Outcomes in Pulmonary Hypertension Associated With Interstitial Lung Disease Versus Pulmonary Arterial Hypertension in Systemic Sclerosis: Data From a Study Identifying Prognostic Factors in Pulmonary Hypertension Associated With Interstitial Lung Disease.特发性肺纤维化相关肺动脉高压与系统性硬化症相关肺动脉高压患者治疗后血流动力学反应及结局比较:特发性肺纤维化相关肺动脉高压预后因素研究数据。
Arthritis Rheumatol. 2021 Feb;73(2):295-304. doi: 10.1002/art.41512. Epub 2020 Dec 29.
6
Clinical characteristics and survival in systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease.系统性硬皮病相关间质性肺疾病肺动脉高压的临床特征和生存。
Chest. 2011 Oct;140(4):1016-1024. doi: 10.1378/chest.10-2473. Epub 2011 Apr 7.
7
Improved transplant-free survival in patients with systemic sclerosis-associated pulmonary hypertension and interstitial lung disease.系统性硬皮病相关性肺动脉高压和间质性肺病患者的移植后生存率提高。
Arthritis Rheumatol. 2014 Jul;66(7):1900-8. doi: 10.1002/art.38623.
8
Mortality and hospitalization outcomes of interstitial lung disease and pulmonary hypertension in the Singapore systemic sclerosis cohort.新加坡系统性硬化症队列中间质性肺病和肺动脉高压的死亡率和住院结局。
Semin Arthritis Rheum. 2020 Jun;50(3):473-479. doi: 10.1016/j.semarthrit.2019.11.005. Epub 2019 Nov 13.
9
Impact of pulmonary hypertension on exercise performance in patients with interstitial lung disease undergoing evaluation for lung transplantation.肺动脉高压对接受肺移植评估的间质性肺疾病患者运动能力的影响。
Respirology. 2014 Jul;19(5):675-82. doi: 10.1111/resp.12306. Epub 2014 May 6.
10
Pulmonary hypertension in interstitial lung disease: prevalence, prognosis and 6 min walk test.特发性肺纤维化相关肺动脉高压:患病率、预后及 6 分钟步行试验。
Respir Med. 2012 Jun;106(6):875-82. doi: 10.1016/j.rmed.2012.02.015. Epub 2012 Mar 15.

引用本文的文献

1
Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD): Back to the Future.与间质性肺疾病相关的肺动脉高压(PH-ILD):回归未来。
Adv Ther. 2025 Apr;42(4):1627-1641. doi: 10.1007/s12325-025-03129-3. Epub 2025 Feb 19.
2
Screening and diagnosis of pulmonary hypertension associated with chronic lung disease (PH-CLD): A consensus statement from the pulmonary vascular research institute's innovative drug development initiative-group 3 pulmonary hypertension.慢性肺病相关肺动脉高压(PH-CLD)的筛查与诊断:肺血管研究所创新药物开发倡议-3型肺动脉高压共识声明
Pulm Circ. 2024 Dec 10;14(4):e70005. doi: 10.1002/pul2.70005. eCollection 2024 Oct.
3
Pulmonary hypertension associated with lung diseases.
与肺部疾病相关的肺动脉高压。
Eur Respir J. 2024 Oct 31;64(4). doi: 10.1183/13993003.01200-2024. Print 2024 Oct.
4
Pulmonary hypertension in the setting of interstitial lung disease: Approach to management and treatment. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative-Group 3 Pulmonary Hypertension.间质性肺疾病背景下的肺动脉高压:管理与治疗方法。肺血管研究所创新药物开发倡议-3组肺动脉高压共识声明。
Pulm Circ. 2024 Jan 10;14(1):e12310. doi: 10.1002/pul2.12310. eCollection 2024 Jan.
5
Pulmonary Hypertension in the Course of Interstitial Lung Diseases-A Personalised Approach Is Needed to Identify a Dominant Cause and Provide an Effective Therapy.间质性肺疾病过程中的肺动脉高压——需要个性化方法来确定主要病因并提供有效治疗。
Diagnostics (Basel). 2023 Jul 13;13(14):2354. doi: 10.3390/diagnostics13142354.
6
Pathogenesis, clinical features, and phenotypes of pulmonary hypertension associated with interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative - Group 3 Pulmonary Hypertension.与间质性肺疾病相关的肺动脉高压的发病机制、临床特征及表型:肺血管研究所创新药物开发计划 - 3组肺动脉高压共识声明
Pulm Circ. 2023 Apr 1;13(2):e12213. doi: 10.1002/pul2.12213. eCollection 2023 Apr.